South Wales, July 8 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "FemHealth360" on March 23. The details about the trademark application no. UK00004177985 published in the journal no. 2025/027 (July 4).
Asclea Tech Ltd filed the trademark application for the below mentioned good(s)/service(s).
Class 9 : Softwareand AI technology namely,downloadable and cloud-based software for tracking, analysing, and managing women's health data; mobile applications for symptom logging, biometric analysis, and wearable device integration; artificial intelligence software for generating personalised health insights and self-advocacy recommendations; data analytics platforms for physiological and behavioural monitoring; software for use with smartwatches, glucose monitors, and health tracking sensors.
Class 10 : Medical Devicesand Sensor Integration namely,wearable health monitoring devices; diagnostic sensors for non-invasive biometrics; software-integrated devices for tracking heart rate, glucose, blood pressure, hormone levels and other health indicators; electronic devices used in conjunction with AI-powered health applications for early detection and wellness screening; non-invasive tools for women's health monitoring.
Class 42 : Technologyand AI Services; Software as a Service (SaaS) for health tracking and symptom analysis; providing temporary use of non-downloadable software for AI-driven health insights; development of algorithms for health risk prediction; design and hosting of platforms integrating biometric, wearable and lifestyle data; scientific research services relating to women's health technology and data analytics.
Class 44 : Healthand wellness services; health and wellness monitoring services; providing information in the field of women's health via AI-generated data analysis; personalised health advisory services based on self-reported and wearable data; non-diagnostic support for medical self-advocacy; consultation and education services relating to hormonal health, reproductive health, and chronic symptom tracking.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004177985
Disclaimer: Curated by HT Syndication.
